Skip to Content
scroll

Australian Clinical Labs Ltd (ACL)

ASX.ACL $3.62

20 MINUTE DELAYED

14 DAYS FREE ACCESS

Join Market Matters and get full access
to all our Opinion + Action

LEARN MORE

ACL $3.62

20 MINUTE DELAYED

TODAY

-1.09 %

1 YEAR RETURN

0.00%

VOLUME

439,769

DIV YIELD

3.28%

PE RATIO

30.42

52 WEEK RANGE

2.14

3.86

ANALYSIS

i

SHARE PRICE ACTIVITY
Last (Price)

3.62

Change

-0.04 (-1.09)

Bid / Ask

3.62 - 3.63

Volume

439,769

Turnover

1,617,355

Open

3.65

Day Range

3.62 - 3.74

VWAP

3.68

Prev Close

3.66

Last Trade

08/11 2:54pm (AEST)

i

KEY INFORMATION
Sector

Healthcare

Shares Issued

171,681,116

NTA/Share

0.00

Last Dividend

0.09

Dividend Ex Date

04 SEP 2024

Dividend Pay Date

27 SEP 2024

i

BROKER CALLS

current

Mean

2.00

Target Price

0.00

BUY

i

CURRENT ()
Revenue

697.07

EBITDA

193.00

Profit

41.70

Earnings Per Share (EPS)

0

Dividend Per Share (DPS)

0

Yield %

3.28

Market Cap

0

Price to Earnings Ratio (P/E)

30.42

i

TARGET PRICE FORECAST

i

ESTIMATES ()
Revenue

734.23

EBITDA

202.61

Profit

37.66

Earnings Per Share (EPS)

0.19

Dividend Per Share (DPS)

0.13

i

BROKER CONSENSUS RECOMMENDATION

BUY

SELL

Target Price

0.00

Lt Growth Rate

0.00

Recommendation (BUY)

2.00
OPINION
image description

Business Summary

Australian Clinical Labs Limited is a private provider of pathology services. Its laboratories perform a range of pathology tests each year for a range of clients, including doctors, specialists, patients, hospitals, and corporate clients. It performs a range of services for doctors, patients, and corporate clients, including routine pathology tests, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology and cytopathology, hematology, allergy and immunology, serology and microbiology, infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing. Its specialist services include molecular cancer services, obstetrics and gynecology, pharmacogenetic testing, gastroenterology, and hospital services. It has operations in Victoria, New South Wales, Western Australia, South Australia, Queensland, and the Northern Territory.

image description

Relevant suggested news and content from the site

image description

Only available to Members

Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required
For membership options and pricing. Click here
Back to top